THU0416 PEGLOTICASE RESPONSE IMPROVEMENT BY CO-TREATMENT WITH METHOTREXATE: RESULTS FROM THE MIRROR OPEN-LABEL CLINICAL TRIAL IN PATIENTS WITH UNCONTROLLED GOUT

MLA

John K. Botson, et al. “Thu0416 Pegloticase Response Improvement by Co-Treatment with Methotrexate: Results from the Mirror Open-Label Clinical Trial in Patients with Uncontrolled Gout.” Annals of the Rheumatic Diseases, vol. 79, June 2020, p. 446.3-446. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b8691fe785a0ff7eb71befc6cff7de0e&authtype=sso&custid=ns315887.

APA

John K. Botson, Michael E. Weinblatt, B. Lamoreaux, K. Obermeyer, Paul M. Peloso, & Jeff Peterson. (2020). Thu0416 Pegloticase Response Improvement by Co-Treatment with Methotrexate: Results from the Mirror Open-Label Clinical Trial in Patients with Uncontrolled Gout. Annals of the Rheumatic Diseases, 79, 446.3-446.

Chicago

John K. Botson, Michael E. Weinblatt, B. Lamoreaux, K. Obermeyer, Paul M. Peloso, and Jeff Peterson. 2020. “Thu0416 Pegloticase Response Improvement by Co-Treatment with Methotrexate: Results from the Mirror Open-Label Clinical Trial in Patients with Uncontrolled Gout.” Annals of the Rheumatic Diseases 79 (June): 446.3-446. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b8691fe785a0ff7eb71befc6cff7de0e&authtype=sso&custid=ns315887.